Spyre Therapeutics, Inc 10-K for FY2019
Spyre Therapeutics, Inc. (SYRE)
10-K
2020-02-24
For: 2019-12-31
View Original
Added on
April 10, 2026
About this 10-K
Spyre Therapeutics, Inc filed this 10-K on February 24, 2020, covering the fiscal year ended December 31, 2019 (FY2019).
Headline figures
Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $3.89M a year earlier
- Net loss
- $78.25M
- compared with a net loss of $44.35M a year earlier